ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,408.42
      -1.73%
      US Tech 100
      17,870.94
      -3.09%
      Dow Jones
      40,345.41
      -1.01%
      Brent Oil
      71.355
      0.66%
      Bitcoin
      54,487.09
      0.58%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      09/08/20246:05PMGlobeNewswire Inc.Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) CongressLSE:AVCTAvacta Group Plc
      09/08/20246:05PMGlobeNewswire Inc.C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024NASDAQ:CCCCC4 Therapeutics Inc
      09/08/20245:26PMPR Newswire (US)Resecurity Partners with Mannai Trading Corporation to Bolster Cybersecurity in Qatar
      09/08/20245:00PMPR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le lundi 9 septembre 2024
      09/08/20245:00PMPR Newswire (Canada)Media Advisory - Prime Minister's itinerary for Monday, September 9, 2024
      09/08/20244:55PMPR Newswire (Canada)Les grands écrans de Hisense repoussent les limites des jeux vidéo au salon IFA 2024
      09/08/20244:30PMPR Newswire (Canada)Government of Canada strengthens support for Sikh culture and heritage
      09/08/20244:30PMPR Newswire (Canada)Le gouvernement du Canada renforce le soutien à la culture et au patrimoine sikhs
      09/08/20243:04PMBusiness WireLa deuxième journée du 11e Sommet annuel mondial sur la sécurité des patients, la science et la technologie souligne l'importance de la collaboration et des technologies de pointe
      09/08/20242:42PMBusiness WireTag 2 des 11. jährlichen Weltgipfels für Patientensicherheit, Wissenschaft und Technologie unterstreicht die Bedeutung von Zusammenarbeit und modernen Technologien
      09/08/20242:35PMPR Newswire (US)ICEYE to deliver SAR satellites and data to Greece's National Satellite Space Project in collaboration with the European Space Agency
      09/08/20242:30PMPR Newswire (Canada)Statement by Minister Qualtrough on the closing of the Paris 2024 Paralympic Games
      09/08/20242:30PMPR Newswire (Canada)Déclaration de la ministre Qualtrough sur la clôture des Jeux paralympiques de Paris 2024
      09/08/20242:28PMPR Newswire (US)ICEYE to deliver SAR satellites and data to Greece's National Satellite Space Project in collaboration with the European Space Agency
      09/08/20242:17PMPR Newswire (US)Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated Clinically Significant Phase II Results, Presented in Oral Session at WCLC 2024
      09/08/20242:00PMPR Newswire (Canada)Statement by the Prime Minister on the closing of the Paris 2024 Paralympic Games
      09/08/20242:00PMPR Newswire (Canada)Déclaration du premier ministre à l'occasion de la clôture des Jeux paralympiques de Paris de 2024
      09/08/20241:47PMPR Newswire (US)RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show strong favorable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancerNYSE:JNJJohnson and Johnson
      09/08/20241:15PMPR Newswire (Canada)AVIS AUX MÉDIAS - Le gouvernement du Canada fera une annonce concernant les soins dentaires
      09/08/20241:15PMPR Newswire (US)Ivonescimab Outperforms Pembrolizumab in Phase 3 Study for First-Line Treatment of PD-L1-Positive Advanced NSCLC In HARMONi-2 Study
      09/08/20241:15PMPR Newswire (Canada)NOTICE TO THE MEDIA - Government of Canada to make an announcement about dental care
      09/08/20241:15PMPR Newswire (US)Perioperative Nivolumab May Provide Meaningful Improvement in Event-Free Survival Compared to only Neoadjuvant Nivolumab Plus Chemotherapy for Resectable NSCLC
      09/08/20241:15PMPR Newswire (US)PanCan Nodule Management Protocol More Effective Than LungRADSv1.1 Method
      09/08/20241:15PMPR Newswire (US)NeoCOAST-2 Data Shows Combination of Durvalumab with novel agents increases pathological responses in resectable NSCLC -- Data Builds on AEGEAN Study Research
      09/08/20241:01PMPR Newswire (US)AdvisorVault's 17a-4 Managed 365 Service: Finally, Guaranteed FINRA Compliance On The Microsoft Cloud
      09/08/202412:25PMBusiness WireNovel Computational Pathology-Based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients with Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial
      09/08/202412:25PMBusiness WireNovel computational pathology-based TROP2 biomarker for datopotamab deruxtecan was predictive of clinical outcomes in patients with non-small cell lung cancer in TROPION-Lung01 Phase III trialNASDAQ:AZNAstraZeneca PLC
      09/08/202412:21PMPR Newswire (US)Akeso's Ivonescimab Head-to-Head Phase III Data Against Pembrolizumab Unveiled at WCLC 2024
      09/08/202412:08PMPR Newswire (US)Kendrick Lamar to Perform at Apple Music Super Bowl LIX Halftime Show Sunday, February 9, 2025, on FOX
      09/08/202411:45AMBusiness WireIvonescimab Monotherapy Reduced the Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC in ChinaNASDAQ:SMMTSummit Therapeutics Inc